Posted by Dale Buss on May 17, 2012 09:02 AM
Dish Network runs into resistance for placing its ad about its ad-skipping DVR.
Pinterest valued at $1.5 billion.
Unilever tests interactive TV concept with NBCU.
Angry Birds footwear? Check.
Apple awarded U.S. patent for soft keyboard as Retina Display patent application for OSX revealed.
Boyd Gaming to buy Peninsula Gaming.
Bristol-Myers Squibb set to lose patent protection for Plavix.
Buca di Beppo has aggressive growth in sight, new CEO says.
CNN hits 15-year low with prime-time ratings.
Comcast's NBC Sports Network will break cable record for Olympics coverage.
Facebook confronts skepticism about its advertising in wake of GM pullout.Continue reading...
Posted by Mark J. Miller on May 25, 2011 10:00 AM
Sick of shelling out big bucks for your Lipitor and other brand-name drugs? Well, it doesn’t appear that you’ll need to do it for a whole lot longer. But you will have to memorize the actual medical name of your medicine rather than such catchy brand names as Zyprexa, Plavix, and Singulair.
They're just a few of the brand-name drugs that will go on the market in a cheaper, generic form in the next two years.
Why? Because the patents on these and other brands will run out and allow for other companies to offer those generics at lower prices since the patent royalties and marketing costs will disappear, creating a boon for consumers and a headache for Big Pharma.Continue reading...